Literature DB >> 26041600

Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).

Anuradha Lala1, Steven E McNulty2, Robert J Mentz2, Shannon M Dunlay2, Justin M Vader2, Omar F AbouEzzeddine2, Adam D DeVore2, Prateeti Khazanie2, Margaret M Redfield2, Steven R Goldsmith2, Bradley A Bart2, Kevin J Anstrom2, G Michael Felker2, Adrian F Hernandez2, Lynne W Stevenson2.   

Abstract

BACKGROUND: Congestion is the most frequent cause for hospitalization in acute decompensated heart failure. Although decongestion is a major goal of acute therapy, it is unclear how the clinical components of congestion (eg, peripheral edema, orthopnea) contribute to outcomes after discharge or how well decongestion is maintained. METHODS AND
RESULTS: A post hoc analysis was performed of 496 patients enrolled in the Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARRESS-HF) trials during hospitalization with acute decompensated heart failure and clinical congestion. A simple orthodema congestion score was generated based on symptoms of orthopnea (≥2 pillows=2 points, <2 pillows=0 points) and peripheral edema (trace=0 points, moderate=1 point, severe=2 points) at baseline, discharge, and 60-day follow-up. Orthodema scores were classified as absent (score of 0), low-grade (score of 1-2), and high-grade (score of 3-4), and the association with death, rehospitalization, or unscheduled medical visits through 60 days was assessed. At baseline, 65% of patients had high-grade orthodema and 35% had low-grade orthodema. At discharge, 52% patients were free from orthodema at discharge (score=0) and these patients had lower 60-day rates of death, rehospitalization, or unscheduled visits (50%) compared with those with low-grade or high-grade orthodema (52% and 68%, respectively; P=0.038). Of the patients without orthodema at discharge, 27% relapsed to low-grade orthodema and 38% to high-grade orthodema at 60-day follow-up.
CONCLUSIONS: Increased severity of congestion by a simple orthodema assessment is associated with increased morbidity and mortality. Despite intent to relieve congestion, current therapy often fails to relieve orthodema during hospitalization or to prevent recurrence after discharge. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifiers: NCT00608491, NCT00577135.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  dyspnea; edema; follow-up studies; heart failure; hospitalization

Mesh:

Substances:

Year:  2015        PMID: 26041600      PMCID: PMC4512849          DOI: 10.1161/CIRCHEARTFAILURE.114.001957

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  27 in total

Review 1.  Congestion in acute heart failure syndromes: an essential target of evaluation and treatment.

Authors:  Mihai Gheorghiade; Gerasimos Filippatos; Leonardo De Luca; John Burnett
Journal:  Am J Med       Date:  2006-12       Impact factor: 4.965

2.  Natriuretic peptides and cardiovascular events: more than a stretch.

Authors:  Marvin A Konstam
Journal:  JAMA       Date:  2007-01-10       Impact factor: 56.272

3.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  J Am Coll Cardiol       Date:  2013-06-05       Impact factor: 24.094

4.  Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial.

Authors:  Mark H Drazner; Anne S Hellkamp; Carl V Leier; Monica R Shah; Leslie W Miller; Stuart D Russell; James B Young; Robert M Califf; Anju Nohria
Journal:  Circ Heart Fail       Date:  2008-09       Impact factor: 8.790

5.  Rehospitalization for heart failure: predict or prevent?

Authors:  Akshay S Desai; Lynne W Stevenson
Journal:  Circulation       Date:  2012-07-24       Impact factor: 29.690

6.  Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial.

Authors:  Andrew P Ambrosy; Peter S Pang; Sadiya Khan; Marvin A Konstam; Gregg C Fonarow; Brian Traver; Aldo P Maggioni; Thomas Cook; Karl Swedberg; John C Burnett; Liliana Grinfeld; James E Udelson; Faiez Zannad; Mihai Gheorghiade
Journal:  Eur Heart J       Date:  2013-01-04       Impact factor: 29.983

Review 7.  Sleep-disordered breathing in heart failure: identifying and treating an important but often unrecognized comorbidity in heart failure patients.

Authors:  Rami Khayat; Roy Small; Lisa Rathman; Steven Krueger; Becky Gocke; Linda Clark; Laura Yamokoski; William T Abraham
Journal:  J Card Fail       Date:  2013-06       Impact factor: 5.712

8.  Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.

Authors:  Marvin A Konstam; Mihai Gheorghiade; John C Burnett; Liliana Grinfeld; Aldo P Maggioni; Karl Swedberg; James E Udelson; Faiez Zannad; Thomas Cook; John Ouyang; Christopher Zimmer; Cesare Orlandi
Journal:  JAMA       Date:  2007-03-25       Impact factor: 56.272

9.  Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.

Authors:  Robb D Kociol; Steven E McNulty; Adrian F Hernandez; Kerry L Lee; Margaret M Redfield; Russell P Tracy; Eugene Braunwald; Christopher M O'Connor; G Michael Felker
Journal:  Circ Heart Fail       Date:  2012-12-18       Impact factor: 8.790

10.  Reduction in mitral regurgitation during therapy guided by measured filling pressures in the ESCAPE trial.

Authors:  Maryse Palardy; Lynne W Stevenson; Gudaye Tasissa; Michele A Hamilton; Robert C Bourge; Thomas G Disalvo; Uri Elkayam; James A Hill; Sharon C Reimold
Journal:  Circ Heart Fail       Date:  2009-04-14       Impact factor: 8.790

View more
  61 in total

Review 1.  Synthesizing Markers of Kidney Injury in Acute Decompensated Heart Failure: Should We Even Keep Looking?

Authors:  Alexander S Manguba; Xavier Vela Parada; Steven G Coca; Anuradha Lala
Journal:  Curr Heart Fail Rep       Date:  2019-12

Review 2.  Drugs' development in acute heart failure: what went wrong?

Authors:  Vincenzo Teneggi; Nithy Sivakumar; Deborah Chen; Alex Matter
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

3.  Utility of the Cardiovascular Physical Examination and Impact of Spironolactone in Heart Failure With Preserved Ejection Fraction.

Authors:  Senthil Selvaraj; Brian Claggett; Sanjiv J Shah; Inder S Anand; Jean L Rouleau; Akshay S Desai; Eldrin F Lewis; Muthiah Vaduganathan; Stephen Y Wang; Bertram Pitt; Nancy K Sweitzer; Marc A Pfeffer; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2019-06-21       Impact factor: 8.790

4.  History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure.

Authors:  Ravi B Patel; Muthiah Vaduganathan; Aruna Rikhi; Hrishikesh Chakraborty; Stephen J Greene; Adrian F Hernandez; G Michael Felker; Margaret M Redfield; Javed Butler; Sanjiv J Shah
Journal:  JACC Heart Fail       Date:  2018-11-05       Impact factor: 12.035

Review 5.  Risk of heart failure progression in patients with reduced ejection fraction: mechanisms and therapeutic options.

Authors:  Edoardo Gronda; Emilio Vanoli; Stefania Sacchi; Guido Grassi; Giuseppe Ambrosio; Claudio Napoli
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

6.  Prevalence and outcome of diuretic resistance in heart failure: comment.

Authors:  Edgar Francisco Carrizales-Sepúlveda; Raymundo Vera-Pineda; Raúl Alberto Jiménez-Castillo; Mario Alberto Benavides-González; Alejandro Ordaz-Farías
Journal:  Intern Emerg Med       Date:  2019-02-20       Impact factor: 3.397

7.  Ptolemy and Copernicus Revisited: The Complex Interplay between the Kidneys and Heart Failure.

Authors:  Steven G Coca
Journal:  Clin J Am Soc Nephrol       Date:  2018-05-17       Impact factor: 8.237

Review 8.  Heart failure and kidney dysfunction: epidemiology, mechanisms and management.

Authors:  Joerg C Schefold; Gerasimos Filippatos; Gerd Hasenfuss; Stefan D Anker; Stephan von Haehling
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

9.  Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure.

Authors:  Javed Butler; Adrian F Hernandez; Kevin J Anstrom; Andreas Kalogeropoulos; Margaret M Redfield; Marvin A Konstam; W H Wilson Tang; G Michael Felker; Monica R Shah; Eugene Braunwald
Journal:  JACC Heart Fail       Date:  2016-08-10       Impact factor: 12.035

Review 10.  Cardiac Rehabilitation to Optimize Medication Regimens in Heart Failure.

Authors:  Parag Goyal; Eiran Z Gorodeski; Zachary A Marcum; Daniel E Forman
Journal:  Clin Geriatr Med       Date:  2019-06-21       Impact factor: 3.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.